2023 Q3 Form 10-Q Financial Statement

#000143774923023598 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $728.5K $737.4K
YoY Change -40.25% -47.3%
Cost Of Revenue $327.9K $427.0K
YoY Change -33.48% -14.51%
Gross Profit $400.5K $310.4K
YoY Change -44.84% -65.5%
Gross Profit Margin 54.98% 42.1%
Selling, General & Admin $1.090M $1.504M
YoY Change -32.58% -12.46%
% of Gross Profit 272.13% 484.43%
Research & Development $173.7K $227.3K
YoY Change -42.55% -34.13%
% of Gross Profit 43.36% 73.21%
Depreciation & Amortization $10.00K $10.68K
YoY Change 81.16% 82.56%
% of Gross Profit 2.5% 3.44%
Operating Expenses $1.270M $1.742M
YoY Change -34.02% -15.8%
Operating Profit -$869.2K -$1.431M
YoY Change -27.46% 22.46%
Interest Expense $10.00K $6.800K
YoY Change -109.08% -104.62%
% of Operating Profit
Other Income/Expense, Net $197.5K $6.805K
YoY Change -279.3% -104.62%
Pretax Income -$671.7K -$1.424M
YoY Change -48.66% 8.24%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$671.7K -$1.424M
YoY Change -48.66% 8.24%
Net Earnings / Revenue -92.21% -193.18%
Basic Earnings Per Share -$0.21 -$0.45
Diluted Earnings Per Share -$0.21 -$0.45
COMMON SHARES
Basic Shares Outstanding 3.185M 3.146M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $470.0K $945.7K
YoY Change -91.23% -86.62%
Cash & Equivalents $463.3K $272.6K
Short-Term Investments $0.00 $673.2K
Other Short-Term Assets $260.0K $144.7K
YoY Change 206.35% 40.72%
Inventory $3.464K $15.46K
Prepaid Expenses
Receivables $82.10K $290.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $810.5K $1.396M
YoY Change -85.28% -80.64%
LONG-TERM ASSETS
Property, Plant & Equipment $350.0K $374.8K
YoY Change -22.34% -14.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.420M $8.424M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $8.770M $8.799M
YoY Change 1845.96% 1910.7%
TOTAL ASSETS
Total Short-Term Assets $810.5K $1.396M
Total Long-Term Assets $8.770M $8.799M
Total Assets $9.581M $10.19M
YoY Change 60.83% 33.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $825.1K $750.1K
YoY Change 11.69% -7.1%
Accrued Expenses $70.00K $68.98K
YoY Change -10.14% -7.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $30.00K $28.88K
YoY Change -96.75% -96.92%
Total Short-Term Liabilities $1.493M $1.568M
YoY Change -37.18% -42.58%
LONG-TERM LIABILITIES
Long-Term Debt $20.00K $25.14K
YoY Change -57.28% -53.46%
Other Long-Term Liabilities $220.0K $232.7K
YoY Change -22.16% -22.45%
Total Long-Term Liabilities $234.4K $257.8K
YoY Change -28.84% -27.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.493M $1.568M
Total Long-Term Liabilities $234.4K $257.8K
Total Liabilities $1.728M $1.826M
YoY Change -36.17% -40.81%
SHAREHOLDERS EQUITY
Retained Earnings -$18.82M -$18.15M
YoY Change 37.68% 46.82%
Common Stock $3.198K $3.270K
YoY Change -75.76% -75.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.29K $15.29K
YoY Change -98.56% -98.38%
Treasury Stock Shares
Shareholders Equity $7.853M $8.368M
YoY Change
Total Liabilities & Shareholders Equity $9.581M $10.19M
YoY Change 60.83% 33.31%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$671.7K -$1.424M
YoY Change -48.66% 8.24%
Depreciation, Depletion And Amortization $10.00K $10.68K
YoY Change 81.16% 82.56%
Cash From Operating Activities -$480.0K -$1.466M
YoY Change -67.0% 17.74%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $2.880K
YoY Change -100.0% -109.42%
Acquisitions
YoY Change
Other Investing Activities $680.0K $1.514M
YoY Change -65.18% 39.9%
Cash From Investing Activities $680.0K $1.511M
YoY Change -64.58% 43.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -22.46K
YoY Change -93.63% -81.73%
NET CHANGE
Cash From Operating Activities -480.0K -1.466M
Cash From Investing Activities 680.0K 1.511M
Cash From Financing Activities -10.00K -22.46K
Net Change In Cash 190.0K 22.76K
YoY Change -38.4% -107.19%
FREE CASH FLOW
Cash From Operating Activities -$480.0K -$1.466M
Capital Expenditures $0.00 $2.880K
Free Cash Flow -$480.0K -$1.469M
YoY Change -66.24% 20.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-3324862 usd
us-gaap Net Income Loss
NetIncomeLoss
-2558542 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21197 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11125 usd
blbx Amortization Of Note Discount Premium
AmortizationOfNoteDiscountPremium
0 usd
blbx Amortization Of Note Discount Premium
AmortizationOfNoteDiscountPremium
26628 usd
CY2023Q2 blbx Lease Right Of Use Asset Accumulated Amortization
LeaseRightOfUseAssetAccumulatedAmortization
249062 usd
CY2022Q4 blbx Lease Right Of Use Asset Accumulated Amortization
LeaseRightOfUseAssetAccumulatedAmortization
213459 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001567900
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1568474 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1852875 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
232667 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
265639 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
257806 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
305253 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3184579
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3184579
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3297927
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3297927
CY2023Q2 blbx Common Stock Payable
CommonStockPayable
0 usd
CY2022Q4 blbx Common Stock Payable
CommonStockPayable
23340 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10679 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5850 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1741722 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2068654 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1431299 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1168766 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
147 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
28952 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13314 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
26628 usd
us-gaap Net Income Loss
NetIncomeLoss
-2558542 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4561671 usd
us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
-0 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
94391 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
63760 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
307274 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
814977 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8424000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8368411 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1173761 usd
us-gaap Share Based Compensation
ShareBasedCompensation
248212 usd
us-gaap Net Investment Income
NetInvestmentIncome
53553 usd
us-gaap Net Investment Income
NetInvestmentIncome
-283799 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
230345 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1808 usd
blbx Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
33702 usd
blbx Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
-124605 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32248 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
221849 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-301912 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-391400 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2717168 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2038532 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2883 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30584 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5417253 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13753390 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8013912 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
14750753 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2593776 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
966779 usd
blbx Repayment Of Senior Secured Notes Payable
RepaymentOfSeniorSecuredNotesPayable
-0 usd
blbx Repayment Of Senior Secured Notes Payable
RepaymentOfSeniorSecuredNotesPayable
60000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14331 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14189 usd
blbx Payments For Common Stock Subscribed
PaymentsForCommonStockSubscribed
15291 usd
blbx Payments For Common Stock Subscribed
PaymentsForCommonStockSubscribed
945449 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29622 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1019638 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-153014 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2091391 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
425578 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2426497 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
272564 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
335106 usd
us-gaap Interest Paid Net
InterestPaidNet
312 usd
us-gaap Interest Paid Net
InterestPaidNet
58195 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
blbx Notes Payable Exchanged With Note Payable
NotesPayableExchangedWithNotePayable
-79100 usd
blbx Retirement Of Treasury Stock
RetirementOfTreasuryStock
1181475 usd
blbx Retirement Of Treasury Stock
RetirementOfTreasuryStock
0 usd
us-gaap Stock Issued1
StockIssued1
8424000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2400000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3378103 usd
us-gaap Net Income Loss
NetIncomeLoss
-3324862 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4546026 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5019882 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2717168 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="text-decoration: underline; ">Use of Estimates.</span> The Company’s financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP. Actual results could differ from those estimates.
CY2023Q2 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
0.2 pure
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
654000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3216280 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5417253 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8013912 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
53553 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
673174 usd
CY2023Q2 us-gaap Share Price
SharePrice
3.51
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
109584
CY2022 blbx Warrants And Rights Outstanding Remaining Term
WarrantsAndRightsOutstandingRemainingTerm
P4Y6M10D
blbx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
0
blbx Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
-0
blbx Class Of Warrant Or Right Exercised In Period Price Per Share
ClassOfWarrantOrRightExercisedInPeriodPricePerShare
0
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
109584
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.25
blbx Warrants And Rights Outstanding Remaining Term
WarrantsAndRightsOutstandingRemainingTerm
P4Y10D
CY2023Q2 blbx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Vested
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsVested
99862
CY2023Q2 blbx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Unvested
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnvested
9722
CY2023Q2 blbx Warrant Nonvested Cost Not Yet Recognized Amount
WarrantNonvestedCostNotYetRecognizedAmount
148776 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
219285
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M6D
us-gaap Operating Lease Expense
OperatingLeaseExpense
63000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
44303 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
89948 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
91122 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
93136 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
95150 usd
CY2023Q2 blbx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
72495 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
486154 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
186116 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
300038 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67371 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
232667 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1000 pure

Files In Submission

Name View Source Status
0001437749-23-023598-index-headers.html Edgar Link pending
0001437749-23-023598-index.html Edgar Link pending
0001437749-23-023598.txt Edgar Link pending
0001437749-23-023598-xbrl.zip Edgar Link pending
blbx-20230630.xsd Edgar Link pending
blkbx20230630_10q.htm Edgar Link pending
ex_555727.htm Edgar Link pending
ex_555728.htm Edgar Link pending
ex_555729.htm Edgar Link pending
ex_555730.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
blbx-20230630_cal.xml Edgar Link unprocessable
blbx-20230630_pre.xml Edgar Link unprocessable
blbx-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
blkbx20230630_10q_htm.xml Edgar Link completed
blbx-20230630_def.xml Edgar Link unprocessable